DE602004002405D1 - Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand - Google Patents

Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand

Info

Publication number
DE602004002405D1
DE602004002405D1 DE602004002405T DE602004002405T DE602004002405D1 DE 602004002405 D1 DE602004002405 D1 DE 602004002405D1 DE 602004002405 T DE602004002405 T DE 602004002405T DE 602004002405 T DE602004002405 T DE 602004002405T DE 602004002405 D1 DE602004002405 D1 DE 602004002405D1
Authority
DE
Germany
Prior art keywords
drug
release
vivo
matrix
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004002405T
Other languages
English (en)
Other versions
DE602004002405T2 (de
DE602004002405T3 (de
Inventor
Luigi Bruschi Stefano De
Sergio Pengo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Pharmaceuticals Holdings Ireland ULC
Original Assignee
Eurand Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33446353&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004002405(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eurand Pharmaceuticals Ltd filed Critical Eurand Pharmaceuticals Ltd
Publication of DE602004002405D1 publication Critical patent/DE602004002405D1/de
Publication of DE602004002405T2 publication Critical patent/DE602004002405T2/de
Application granted granted Critical
Publication of DE602004002405T3 publication Critical patent/DE602004002405T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DE602004002405T 2003-05-14 2004-05-14 Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand Expired - Lifetime DE602004002405T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE20030366 2003-05-14
IE20030366 2003-05-14
EP04741578A EP1628642B2 (de) 2003-05-14 2004-05-14 Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand
PCT/EP2004/050814 WO2004100932A1 (en) 2003-05-14 2004-05-14 Controlled drug release composition resistant to in vivo mechanic stress

Publications (3)

Publication Number Publication Date
DE602004002405D1 true DE602004002405D1 (de) 2006-10-26
DE602004002405T2 DE602004002405T2 (de) 2007-09-06
DE602004002405T3 DE602004002405T3 (de) 2013-06-20

Family

ID=33446353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004002405T Expired - Lifetime DE602004002405T3 (de) 2003-05-14 2004-05-14 Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand

Country Status (7)

Country Link
US (1) US20070009596A1 (de)
EP (1) EP1628642B2 (de)
AT (1) ATE339192T1 (de)
DE (1) DE602004002405T3 (de)
ES (1) ES2273271T5 (de)
PL (1) PL1628642T3 (de)
WO (1) WO2004100932A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1847258T5 (pl) † 2006-04-13 2013-06-28 Acino Pharma Ag Częściowe glicerydy jako środki poślizgowe dla kompozycji farmaceutycznych zawierających pochodne tieno[3,2-c]pirydyny
CN101639471A (zh) * 2009-08-21 2010-02-03 天津中医药大学 一种用于评价药物固体制剂溶出/吸收过程的装置
WO2011090724A2 (en) * 2009-12-29 2011-07-28 Impax Laboratories, Inc. Gastroretentive solid oral dosage forms with lipid-based low-density excipient
WO2011146300A1 (en) * 2010-05-17 2011-11-24 Merck Sharp & Dohme Corp. Novel prolylcarboxypeptidase inhibitors
CN105651822A (zh) * 2014-11-14 2016-06-08 湘潭大学 固体制剂活性物溶出性质的测试方法和测试装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
FR2656525A1 (fr) * 1989-12-29 1991-07-05 Delalande Sa Formes d'administration de medicament a liberation controlee et leur procede de fabrication.
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
AR030557A1 (es) † 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
GB0125088D0 (en) † 2001-10-18 2001-12-12 Smithkline Beecham Cork Ltd New use

Also Published As

Publication number Publication date
ES2273271T3 (es) 2007-05-01
EP1628642A1 (de) 2006-03-01
PL1628642T3 (pl) 2007-01-31
DE602004002405T2 (de) 2007-09-06
ES2273271T5 (es) 2013-05-21
WO2004100932A1 (en) 2004-11-25
EP1628642B1 (de) 2006-09-13
ATE339192T1 (de) 2006-10-15
US20070009596A1 (en) 2007-01-11
DE602004002405T3 (de) 2013-06-20
EP1628642B2 (de) 2013-01-23

Similar Documents

Publication Publication Date Title
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
NO20075046L (no) Gastroresistente farmasoytiske formuleringer inneholdende rifaximin
WO2007089745A3 (en) Novel compounds with high therapeutic index
IN2012DN00407A (de)
ECSP088240A (es) Composición de trazodona para administración una vez por día
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
CY1111433T1 (el) Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης
NZ600039A (en) Biocompatible biodegradable fumagillin analog conjugates
NO20015584D0 (no) Lantidsvarende insulintrofiske peptider
CA2620374A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
MY147450A (en) Pharmaceutical combination
MX366832B (es) Composiciones de farmaco de liberacion sostenida convenientemente implantables.
WO2005039499A3 (en) Rapidly disintegrating film
ECSP088569A (es) Nuevos derivados de furopirimidina acíclicos sustituidos y uso de los mismos para el tratamiento de enfermedades cardiovasculares
NO20034504D0 (no) Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet
DE602004002405D1 (de) Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand
ATE303137T1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
BRPI0607976A2 (pt) composição farmacêutica e uso de uma composição
BRPI0418305A (pt) composições farmacêuticas compreendendo um extrato de euphorbia prostrata
BR0314781A (pt) Composição de polìmero e formas de dosagem compreendendo a mesma
RS20060435A (en) Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug
MD2516C2 (ro) Remediu medicamentos antiinflamator, antiseptic şi antifungic sub formă de gel
RS20050772A (en) Pharmaceutical compositions comprising an extract of euphorbia prostrata
EA200701525A1 (ru) Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением
ECSP045210A (es) 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco

Legal Events

Date Code Title Description
8363 Opposition against the patent